Related Experiment Video
Updated: Aug 1, 2026
18:50
Microsurgical Clip Obliteration of Middle Cerebral Aneurysm Using Intraoperative Flow Assessment
Published on: September 25, 2009
Decision analysis for small, asymptomatic intracranial arteriovenous malformations
J McInerney1, D A Gould, J D Birkmeyer
1Department of Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.
Neurosurgical Focus
|February 10, 2006
Summary
Microsurgery offers better long-term quality of life for asymptomatic arteriovenous malformations (AVMs) compared to observation or radiosurgery. This is based on a decision analysis model considering risks and benefits of each treatment.
Area of Science:
- Neurosurgery
- Medical Decision Making
- Radiology
Background:
- Asymptomatic intracranial arteriovenous malformations (AVMs) present complex treatment decisions due to limited data.
- Evaluating treatment strategies requires quantifying risks and benefits.
Purpose of the Study:
- To model and compare the long-term outcomes of observation, microsurgery, and stereotactic radiosurgery for asymptomatic AVMs.
- To quantify risks and benefits associated with each treatment strategy using decision analysis.
Main Methods:
- A comprehensive Markov model was developed using literature data on AVM treatment risks and outcomes.
- Sensitivity analysis was performed to identify key influential variables and strategy crossover points.
- Quality-adjusted life years (QALYs) were calculated for each treatment strategy.
Main Results:
- Microsurgery yielded the highest quality-adjusted life years (21.53 QALYs) compared to stereotactic radiosurgery (16.97 QALYs) and observation (16.40 QALYs).
- Major neurological morbidity and mortality were the most critical factors influencing treatment outcomes.
- A perioperative complication rate below 6.8% is necessary for microsurgery to be favored; a latent period complication rate below 0.7% is needed for radiosurgery.
Conclusions:
- Microsurgery is the favored treatment for asymptomatic AVMs when performed by experienced surgeons with a combined major neurological morbidity and mortality rate below 6.8%.
- This approach maximizes long-term quality of life for patients.
